Pharmalex

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AEF0217 in Participants With Down Syndrome	Abnormalities, Multiple, Cognition Disorders, Cognitive Dysfunction, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Down syndrome, Neurobehavioral Manifestations, Neurologic Manifestations, chromosomal disorder, cognitive disorder, hereditary disease, intellectual disability, nervous system disorder, psychiatric disorder	Recruiting	Phase 2	2026-04-08		NCT07334912
Evaluation of Performance, Safety and Benefit of the Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation	Bone Regeneration; Safety Issues	Recruiting	Not applicable	2024-05-29		NCT06383377

Clinical trials